ArticleSurgical endoscopy2026
Impact of the fibrosis-4 index on postoperative complications in patients undergoing laparoscopic liver resection.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe objective of this study was to evaluate the relationship between preoperative fibrosis-4 (FIB-4) index and postoperative complications in the patients undergoing laparoscopic liver resection (LLR) for liver tumors.
methodsThe 196 patients undergoing LLR were retrospectively analyzed. The patients with the FIB-4 index over 2.67 were classified as the high FIB-4 group. Clinicopathological characteristics and the incidence of postoperative major complications were compared between the high FIB-4 and standard groups. Inverse probability of treatment weighting (IPTW) analysis using propensity scores was performed to minimize selection bias in comparisons between the two groups.
resultsAmong the 196 patients, 92 (47%) were classified into the high FIB-4 group, and the remaining 104 (53%) were classified into the standard FIB-4 group. Postoperative major complications developed in 20 patients (10%). Multiple indicators of liver function and liver fibrosis were significantly worse in the high FIB-4 group. Blood loss per unit liver transection area and operation time per unit liver transection area were significantly greater in the high FIB-4 group (p = 0.009 and p = 0.004, respectively). The incidence of major postoperative complications was significantly higher in the high FIB-4 group (p = 0.009). These differences remained significant after IPTW adjustment.
conclusionsA high FIB-4 index was significantly associated with increased intraoperative blood loss and a higher incidence of postoperative complications following LLR.
Indexed as
Identifiers
42410061What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.